| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $108.5M | +122.9% |
| R&D Expense | $358.7M | +35.2% |
| SG&A Expense | $90.5M | +14.4% |
| Operating Income | -$340.7M | -15.2% |
| Income Tax | $21K | +103.7% |
| Net Income | -$326.0M | -12.2% |
| EPS (Basic) | -$2.60 | -8.8% |
| EPS (Diluted) | -$2.60 | -8.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $218.0M | -25.7% |
| Short-term Investments | $1.12B | +95.5% |
| Current Assets | $1.37B | +52.9% |
| Total Assets | $1.46B | +4.0% |
| Current Liabilities | $363.9M | -3.8% |
| Total Liabilities | $417.8M | -5.4% |
| Stockholders' Equity | $1.04B | +8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$244.7M | -15.8% |
| Capital Expenditures | $17.8M | +109.8% |
| Investing Cash Flow | -$141.4M | -553.8% |
| Financing Cash Flow | $310.7M | +1505.7% |
| Free Cash Flow | -$262.5M | -19.4% |